Efficacy of thoracic endovascular aortic repair versus medical therapy for treatment of type B aortic dissection.

ABSTRACT:

Background

Techniques in endovascular therapy have evolved to offer a promising alternative to medical therapy alone for Type B aortic dissections (TBADs).

Aim

The aim of this meta-analysis was to compare mortality and overall complications between thoracic endovascular aortic repair (TEVAR) and best medical therapy (BMT) in patients with TBADs.

Methods

We included randomized control trials and prospective or retrospective cohort studies that compared TEVAR and BMT for the treatment of type B aortic dissection. Multiple electronic databases were searched.

Results

Thirty-two cohort studies including 150,836 patients were included. TEVAR was associated with a significantly lower 30-day mortality rate than BMT (RR = 0.79, CI = 0.63, 0.99, P = 0.04), notably in pat

SUBMITTER: Motawea KR 

PROVIDER: S-EPMC11391845 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature